Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
CF Finance Acquisition Corp. III Announces Registration Statement Effectiveness and Special Meeting Date to Approve Business Combination with AEye, Inc.
-
Anthem (ANTM) PT Raised to $455 at Cantor Fitzgerald
-
'Sunshine and Blue Skies' Ahead For Johnson & Johnson (JNJ) Following Strong Q2 Beat
-
3 Biotech Penny Stocks To Watch Seeing Explosive Gains In 2021
-
Companies with NDRs 7/21
-
Silver Spike Investment Corp. Announces Proposed Initial Public Offering
-
Form 424B3 Cantor Fitzgerald Income
-
IMV Inc. Closes Previously Announced Public Offering
-
Ardelyx's (ARDX) Shares Plunge as Tenapanor's Deficiencies Identified by FDA 'Take Approval Off the Table'
-
Cantor Fitzgerald Investment Advisors Acquires the Business of Smith Group Asset Management
-
Companies with NDRs 7/20
-
TortoiseEcofin Acquisition Corp. III (TRTL.U) Prices 30M Share IPO at $10/unit
-
Makor Capital Hires Benjamin Kupfer to Makor Investment Banking Division
-
TortoiseEcofin Acquisition Corp. III Announces Pricing of $300,000,000 Initial Public Offering
-
TortoiseEcofin Acquisition Corp. III Announces Pricing of $300,000,000 Initial Public Offering
-
TortoiseEcofin Acquisition Corp. III Announces Launch of Initial Public Offering
-
TortoiseEcofin Acquisition Corp. III Announces Launch of Initial Public Offering
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Jun 30
-
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
UnitedHealth Group (UNH) PT Raised to $450 at Cantor Fitzgerald
-
AEye Accelerates Rollout of Its Business Model Across Automotive and Industrial Markets
-
IMV Inc. (IMV) Prices 14.3M Share Offering at $1.75/sh
-
IMV Inc. Announces Pricing of Public Offering
-
Orchid Island Capital Announces Estimated Second Quarter 2021 Results, July 2021 Monthly Dividend and June 30, 2021 RMBS Portfolio Characteristics
-
IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Units
-
AcelRX Pharmaceuticals (ACRX) is 'Making the Right Moves' with Recent Licensing Deals
-
Lidar supplier AEye inks deals with Continental, TuSimple
-
TuSimple and AEye Partner to Deploy Long-Range LiDAR for Autonomous Trucking
-
Companies with NDRs 7/14
-
Celldex (CLDX) Prices Upsized 5.95M Share Offering at $42/sh
-
Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock
-
Verano CEO to Participate in Cantor Fitzgerald Investor Fireside Chat
-
Verano CEO to Participate in Cantor Fitzgerald Investor Fireside Chat
-
Celldex (CLDX) Announces up to $175M Share Offering
-
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
-
Celldex Therapeutics (CLDX) PT Raised to $61 at Cantor Fitzgerald
-
EmpiRx Health Announces Strategic Growth Investment from Nautic Partners
-
AEye Establishes New Benchmark for LiDAR Performance with 1000 Meter Range in Rain, Behind Windshield Glass
-
Form 8-K Cantor Fitzgerald Income For: Jun 29
-
Pre-Open Stock Movers 07/09: (STMP) (GALT) (CARV) Higher; (SGH) (DCT) (CLB) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Novan (NOVN) at Overweight
-
Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares
-
Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares
-
Alpha Tau and Healthcare Capital Corp. (HCCC) to Combine to Create Publicly Traded Company Focused on Transforming Treatment of Solid Tumors
-
Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation
-
Best Reddit Penny Stocks to Buy Now? 7 for Your July Small-Caps List
-
Surging US Treasuries drop benchmark 10-year yield to 1.3%
-
Pre-Open Stock Movers 07/07: (DARE) (OPNT) (BHVN) Higher; (BSQR) (IDYA) (LOAN) Lower (more...)
-
Short exit stampede at 1.4% drives U.S. Treasury yield slump, traders say
-
Cantor Fitzgerald Starts Jaguar Animal Health (JAGX) at Overweight

